GlobeNewsWire
02 Jun 2026, 19:47 UTC · 2h ago
Search tags
Story key points
2 claims · impact-rated
Culper Research released a report alleging ADMA Biologics engaged in channel stuffing to inflate revenue growth. — Allegations of financial manipulation and revenue inflation are severe and typically lead to significant valuation haircuts and loss of investor trust.
-0.80The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit against ADMA Biologics. — Formal legal action increases the likelihood of financial settlements and creates a long-term overhang of legal risk and corporate distraction.
-0.40Ticker attribution
Model heads
The company is facing a class action lawsuit investigation following allegations of channel stuffing and revenue inflation.
Continue reading
6 related stories
The company is mentioned as being under investigation for potential securities claims by the Rosen Law Firm.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
GlobeNewsWire
1h ago
